BAK Other Income/Expenses (Net)

Braskem SA ADR · Other Income/Expenses (Net)

BAK logo

BAK Other Income/Expenses (Net)

Latest reported-R$1.59B BRL
BAK TTM Other Income/Expenses (Net) · BRL (-R$230.68M → -R$1.59B)
High-resolution chart · PNG

BAK other income/expenses (net) history

Trailing twelve months (TTM) · BRL. Each value covers four complete reported quarters.

Braskem SA ADR Other Income/Expenses (Net) — Trailing twelve months (TTM) (BRL)
Period endingOther Income/Expenses (Net) (BRL)
-1,587,000,000
-717,000,000
-1,170,000,000
-8,545,000,000
-9,215,000,000
-15,506,000,000
-18,253,000,000
-11,071,000,000
-11,156,000,000
-5,133,000,000
-3,455,000,000
-3,190,000,000
-2,468,000,000
-6,021,000,000
-4,538,002,000
-7,949,389,000
-9,880,523,000
-5,172,197,000
-9,766,195,000
-4,875,808,000
-3,081,674,000
-6,820,000,000
-9,611,000,000
-13,206,825,000
-13,407,671,000
-11,690,311,000
-6,252,245,000
-4,338,855,000
-3,078,528,000
-4,633,456,000
-4,359,190,000
-6,251,501,000
-6,695,271,000
-4,916,397,000
-4,825,985,000
-7,061,402,000
-7,170,826,000
-8,797,136,000
-9,831,164,000
-6,033,001,000
-4,887,372,000
-3,437,591,000
-2,579,301,000
-1,962,301,000
-2,414,153,000
-2,248,032,000
-2,181,183,000
-2,144,183,000
-2,049,054,000
-2,228,605,000
-1,776,261,000
-1,912,261,000
-1,942,454,000
-3,373,128,000
-3,372,437,000
-3,383,579,000
-4,880,372,000
-2,856,825,000
-2,806,672,000
-2,499,892,000
-287,896,000
105,360,000
-280,026,000
257,736,000
94,533,000
973,607,000
1,207,408,000
-2,992,688,000
-3,045,688,000
-3,797,644,040
-3,476,435,040
44,763,267
109,572,103
160,957,231
-90,958,982
-608,433,765
-605,556,309
-1,097,220,194
-932,710,083
16,406,954
17,547,063
19,166,589
-49,471,686
-66,663,667
-70,349,659
-76,662,452
-31,194,445
-4,956,904
-25,811,505
215,898,079
124,667,036
-3,234,319,882
-3,210,598,210
-3,797,491,185
-3,848,722,258
-742,193,807
-712,663,913
-413,075,087
-348,191,775
-117,594,628
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.